Thomas Edekling

Learn More
BACKGROUND KRAS mutations represent key alterations in colorectal cancer development and lead to constitutive EGFR signaling. Since EGFR inhibition represents a therapeutic strategy in advanced colorectal cancer, KRAS mutation analysis has quickly been introduced as a treatment-predictive test. METHODS We used a real-time PCR based method to determine(More)
  • 1